Cytotrait 🇬🇧

Seed · £3m

University of Manchester spinout engineering organelle genes for crop traits

About Cytotrait

Cytotrait specializes in developing novel traits for agriculture through its proprietary MOSS technology, which enables the introduction of genes into chloroplasts and mitochondria, achieving rapid homoplasmy for enhanced trait expression. This method facilitates improved crop resilience, yield, and sustainability while potentially reducing phytotoxicity and streamlining regulatory processes.

Cytotrait is a UK-based company founded in 2023, now around 5 people. It has raised $3.8M in disclosed funding.

Its investors also appear on FundFinder's most-active lists for Seed · DeepTech (80 funds), Seed · Climate & Sustainability (80 funds), Seed · Life Sciences (32 funds).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Cytotrait? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Seed · £3m · Mar 2026

InvestorsUIUK Innovation & Science Seed Fund (UKI2S)

UK Innovation & Science Seed Fund (UKI2S) — Evergreen, government-backed pre-seed+ fund managed by Future Planet Capital. · cheques up to £1.5M

Read the announcement ↗

Raising your own round? See which European funds fit →